Since rejoining Theradex Oncology in 2016, Judy DeChamplain has direct line- management responsibilities for Clinical Operations, consisting of 7 key functional areas. Judy has 27 years of experience in Oncology Clinical Trials, obtained from both Theradex Oncology and Bristol-Myers Squibb. Her experience includes, but is not limited to; the design, conduct and execution of Oncology Phase I-IV trials, vendor management and project management. She has led teams in many successful regulatory submissions (US and worldwide), providing extensive planning, implementation and delivery of strategy, program plans and execution.
In addition to commercial operations support, Judy provides support to the Theradex Oncology NCI/CTMS contract, more specifically to the Data Safety Monitoring Board (DSMB), program of studies. Judy is a member of the Theradex Oncology Board of Directors.